Jaws Acquisition Corp. (NYSE:JWS) announced in an 8-K filing this afternoon that its shareholders approved its combination with Cano Health at a special meeting earlier today.
The deal was overwhelmingly approved with 75.1% of shares participating in the vote, and the parties expect the transaction to close tomorrow June 3. Shares and warrants of combined entity are expected to begin trading on the NYSE on June 4 under the symbols “CANO” and “CANO.WS”, respectively.
Jaws did not share redemption figures in its filing, but they are unlikely to be significant as its shares closed at $14.51 on May 28, the day of its redemption deadline. This deal along with Deerfield (NASDAQ:DFHT)’s combination with fellow Medicare Advantage-focused CareMax have both been warmly received as Deerfield also closed at $14.50 today.
The first SPAC deal with a Medicare Advantage player of the past year – Social Capital III’s merger with Clover Health (NASDAQ:CLOV) – has fared less well, generally trading below $10 since late February. But, its performance includes external factors including a short seller report and regulatory probes.
Jaws and Cano initially announced their $4.4 billion deal on November 12. Cano serves more than 103,000 Medicare Advantage patients through 564 primary care physicians in Florida, Texas, Nevada, and Puerto Rico.
Most measures on the shareholders’ ballot passed by wide margins but some governance proposals were more controversial than others with one receiving 37.9% of votes against. For a full list of measures and vote tallies, click HERE.
ADVISORS
- Moelis & Company is acting as financial advisor to Cano Health.
- Credit Suisse is serving as financial advisor and exclusive capital markets advisor to Cano Health. Credit Suisse is also serving as exclusive placement agent on the private offering.
- Goodwin Procter LLP is serving as legal counsel to Cano Health and Cravath Swaine & Moore LLP is serving as counsel to certain shareholders, including members of Company management.
- Kirkland & Ellis LLP is serving as legal counsel to Jaws Acquisition Corp.
Despite a week of general pull-backs in the market, fintech firm Ibotta (NYSE:IBTA) nonetheless took the dive and had a good week debuting via a traditional IPO in the choppy waters. The company, which provides app-based consumer cashback discounts on purchases, priced its IPO at $88, above its proposed range of $76 to $84, and...
At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...